Doctors & patients are saying about ''...

" is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI 

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP. 

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD  Johns Hopkins,
Baltimore, MD

Doctors & patients are saying about 'Beat Your A-Fib'...

"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, 
Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient, 
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA

Editorial: EP’s Million Dollar Club—Are Payments to Doctors Buying Influence?

By Steve S. Ryan, October, 2015

In 2014, the pharmaceutical and medical device industries paid out billions to doctors and teaching hospitals. What are they getting for their money? Are they paying for ‘influence’ at the expense of patients?

The EP’s Million Dollar Club

Drug and medical device makers reported payments to seventeen Cardiologists of at least $1 million each from August 2013 through 2014. The payments were for consulting, travel, royalties and other fees. The largest dollar recipients were those who developed a new interventional cardiology device and sold it to one of the big medical device companies.

Among the seventeen doctors are several Electrophysiologists (EPs):

 Dr. Sanjiv Narayan$10,990,510Mostly from the sale of Topera to Abbott
 Dr. Eric Prystowsky $2,829,957Mostly from the sale of Topera to Abbott
 Dr. Benzy Padanilam  $1,018,500Mostly from the sale of Topera to Abbott

$300 Million in Conflicts of Interest?

More routine activities can garner considerable medical industry payments for many thousands of additional cardiovascular healthcare professionals (who don’t invent a device or start a company). For example, Dr. Peter Kowey received $544,000.

Between August 2013 and December 2014, the medical industry paid $300 million to cardiologists and other related healthcare professionals for consulting, speaking and other various activities. Receiving a total of $299,050,686 were 31,379 doctors; 1,639 of those received over $50,000.

This doesn’t include larger sums paid to support healthcare research, or payments for ownership and investor interests.

And the Big Winner is…Anticoagulant Drugs

The new anticoagulants (NOACs) aimed at A-Fib patients for stroke prevention are among the top ten drugs promoted by the pharmaceutical industry. The number of payments to doctors linked to specific drugs are:

 Eliquis145,000 payments
 Xarelto 124,000 payments
 Pradaxa 74,000 payments

As a healthcare consumer, do these payments related to a certain NOAC concern you? They do me!

Reporting Payments to Physicians Now Required by Law

Do the pharmaceutical and medical device industries ‘influence’ doctors through large dollar payments (or other “transfers of value”)? We can only speculate.

In the U.S. under the Sunshine Act [part of the 2010 Patient Protection and Affordable Care Act (PPACA)], we can now research if a doctor has received such payments.

The Center for Medicare and Medicaid Services (part of the U.S. Department of Health and Human Services) is responsible for Open Paymentsthe federally run program that collects the information about these financial relationships and makes it available to consumers. The second year of Open Payments data is now available.

The Open Payments online database along with the ProPublica Dollars for Docs project make it possible to look up payment history for individual physicians, teaching hospitals and companies.

Note: It’s currently hard to isolate data about EPs, specifically, and the Open Payments data doesn’t include all disbursements such as industry payments to sponsors of Continuing Medical Education (CME) courses. (Almost all CME courses are paid for by the medical industry.) But it’s a beginning.

What This Means to Patients

Industry Money a Form of Recognition? Most doctors and U.S. teaching hospitals are not ashamed or embarrassed to receive industry money. For most it is a badge of honor and a recognition of their importance in the industry.

A variety of doctors and U.S. teaching hospitals accept medical industry money, for example, for promotional talks, research, to speak at conferences, consult, etc. It’s reasonable they be reimbursed for their time and effort.

Or is it a Form of Influence? Like death and taxes, medical conflicts of interest are inevitable.

How much does ‘Conflicts of Interest’ factor in to the choices, recommendations and purchases made by these doctors?

For example, Dr. Philip Sager who received $350,000 from the medical industry, has served several times as a member and the chair of the FDA’s Cardiovascular and Renal Advisory Committee. Another frequent FDA panel member is Dr. Sanjay Kaul who earned $250,000 during this same period.

I know of only one medical center in the US that prohibit these types of medical conflicts of interest: The Mayo Clinic.

Legislation to Prevent Conflicts of Interest? Currently, it isn’t possible in the US to legislate away medical conflicts of interest.

Even if we could pass conflicts of interest laws, the medical industry is very creative. They would find other ways to influence doctors.

There is Hope: Transparency and Disclosure. At the last heart-related conference I attended, every presenter’s first slide described their conflicts of interest. The same information was also listed in a brochure given to all the conference attendees. Some doctors even included approximate dollar amount terms such as “significant.”


As healthcare consumers in the US, the most we can hope for right now is transparency and disclosure. The Sunshine Law goes a long way in telling us if our prescribing doctor or the influential speaker at a conference has conflicts of interest.

References for this article
Husten, Larry. CardioBrief: Cardiologists in the Sunshine̶—Analysis of CMS database shows some docs pocketed millions from drug and device makers. Public Health and Policy 07.23.2015.

Moy, D. R, Payment disclosures under the sunshine law: is the forecast cloudy? Published on the Kern Augustine Conroy & Schoppmann, P.C. website. Accessed Sept 27 2015. URL:

About the Open Payments program. Published on June 30, 2015. URL:

Dollars for Docs: How Industry Dollars Reach Your Doctors. Pro Publica Accessed Sept 27 2015. URL:

Follow Us
facebook - A-Fib.comtwitter - A-Fib.comlinkedin - A-Fib.compinterest - A-Fib.comYouTube: A-Fib Can be Cured! -

We Need You Help be self-supporting-Use our link to Amazon is a
501(c)(3) Nonprofit

Your support is needed. Every donation helps, even just $1.00. top rated by since 2014 

Home | The A-Fib Coach | Help Support | A-Fib News Archive | Tell Us What You think | Press Room | GuideStar Seal | HON certification | Disclosures | Terms of Use | Privacy Policy